Cargando…
Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma
Saliva is rich in proteins, DNA, RNA and microorganisms, and can be regarded as a biomarker library. In order to explore a noninvasive and simple means of early screening for liver cancer, proteomics was used to screen salivary markers of hepatitis B associated liver cancer. We used mass spectrometr...
Autores principales: | He, Jiaoxia, Zheng, Zhongling, Liu, Tingting, Ao, Yupei, Yang, Yixuan, Hu, Huaidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467997/ https://www.ncbi.nlm.nih.gov/pubmed/36096917 http://dx.doi.org/10.1038/s41598-022-18894-2 |
Ejemplares similares
-
Efficacy of aerobic and resistance exercises in improving visceral adipose in
patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled
trials
por: Fu, Lixiang, et al.
Publicado: (2022) -
Orosomucoid in liver diseases
por: Elpek, Gulsum Ozlem
Publicado: (2021) -
Orosomucoid, a New Biomarker in the Association between Obesity and Periodontitis
por: Rangé, Hélène, et al.
Publicado: (2013) -
Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas
por: Fang, Tao, et al.
Publicado: (2015) -
Orosomucoid-1 Expression in Ameloblastoma Variants
por: García-Muñoz, Alejandro, et al.
Publicado: (2016)